149 related articles for article (PubMed ID: 35505611)
1. Conformational dynamics of the membrane enzyme LspA upon antibiotic and substrate binding.
Caldwell TA; Vickery ON; Colburn JD; Stansfeld PJ; Columbus L
Biophys J; 2022 Jun; 121(11):2078-2083. PubMed ID: 35505611
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of lipoprotein signal peptidase II action and inhibition by the antibiotic globomycin.
Vogeley L; El Arnaout T; Bailey J; Stansfeld PJ; Boland C; Caffrey M
Science; 2016 Feb; 351(6275):876-80. PubMed ID: 26912896
[TBL] [Abstract][Full Text] [Related]
3. Unstable Mechanisms of Resistance to Inhibitors of Escherichia coli Lipoprotein Signal Peptidase.
Pantua H; Skippington E; Braun MG; Noland CL; Diao J; Peng Y; Gloor SL; Yan D; Kang J; Katakam AK; Reeder J; Castanedo GM; Garland K; Komuves L; Sagolla M; Austin CD; Murray J; Xu Y; Modrusan Z; Xu M; Hanan EJ; Kapadia SB
mBio; 2020 Sep; 11(5):. PubMed ID: 32900806
[TBL] [Abstract][Full Text] [Related]
4. Deletion of a previously uncharacterized lipoprotein lirL confers resistance to an inhibitor of type II signal peptidase in
Huang KJ; Pantua H; Diao J; Skippington E; Volny M; Sandoval W; Tiku V; Peng Y; Sagolla M; Yan D; Kang J; Katakam AK; Michaelian N; Reichelt M; Tan MW; Austin CD; Xu M; Hanan E; Kapadia SB
Proc Natl Acad Sci U S A; 2022 Sep; 119(38):e2123117119. PubMed ID: 36099298
[No Abstract] [Full Text] [Related]
5. Genetic redundancy, proximity, and functionality of lspA, the target of antibiotic TA, in the Myxococcus xanthus producer strain.
Xiao Y; Wall D
J Bacteriol; 2014 Mar; 196(6):1174-83. PubMed ID: 24391051
[TBL] [Abstract][Full Text] [Related]
6. The lspA gene, encoding the type II signal peptidase of Rickettsia typhi: transcriptional and functional analysis.
Rahman MS; Ceraul SM; Dreher-Lesnick SM; Beier MS; Azad AF
J Bacteriol; 2007 Jan; 189(2):336-41. PubMed ID: 17098907
[TBL] [Abstract][Full Text] [Related]
7. Computational Design of Cyclic Peptide Inhibitors of a Bacterial Membrane Lipoprotein Peptidase.
Craven TW; Nolan MD; Bailey J; Olatunji S; Bann SJ; Bowen K; Ostrovitsa N; Da Costa TM; Ballantine RD; Weichert D; Levine PM; Stewart LJ; Bhardwaj G; Geoghegan JA; Cochrane SA; Scanlan EM; Caffrey M; Baker D
ACS Chem Biol; 2024 May; 19(5):1125-1130. PubMed ID: 38712757
[TBL] [Abstract][Full Text] [Related]
8. Role of prolipoprotein diacylglyceryl transferase (Lgt) and lipoprotein-specific signal peptidase II (LspA) in localization and physiological function of lipoprotein MsmE in Streptococcus mutans.
Arimoto T; Igarashi T
Oral Microbiol Immunol; 2008 Dec; 23(6):515-9. PubMed ID: 18954360
[TBL] [Abstract][Full Text] [Related]
9. LspA-independent action of globomycin on Mycobacterium tuberculosis.
Banaiee N; Jacobs WR; Ernst JD
J Antimicrob Chemother; 2007 Aug; 60(2):414-6. PubMed ID: 17579235
[TBL] [Abstract][Full Text] [Related]
10. Targeting Lipoprotein Biogenesis: Considerations towards Antimicrobials.
El Arnaout T; Soulimane T
Trends Biochem Sci; 2019 Aug; 44(8):701-715. PubMed ID: 31036406
[TBL] [Abstract][Full Text] [Related]
11. The type II signal peptidase of Legionella pneumophila.
Geukens N; De Buck E; Meyen E; Maes L; Vranckx L; Van Mellaert L; Anné J; Lammertyn E
Res Microbiol; 2006 Nov; 157(9):836-41. PubMed ID: 17005379
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein processing is required for virulence of Mycobacterium tuberculosis.
Sander P; Rezwan M; Walker B; Rampini SK; Kroppenstedt RM; Ehlers S; Keller C; Keeble JR; Hagemeier M; Colston MJ; Springer B; Böttger EC
Mol Microbiol; 2004 Jun; 52(6):1543-52. PubMed ID: 15186407
[TBL] [Abstract][Full Text] [Related]
13. Structural insights into lipoprotein N-acylation by
Noland CL; Kattke MD; Diao J; Gloor SL; Pantua H; Reichelt M; Katakam AK; Yan D; Kang J; Zilberleyb I; Xu M; Kapadia SB; Murray JM
Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6044-E6053. PubMed ID: 28698362
[TBL] [Abstract][Full Text] [Related]
14. Conformational flexibility of the leucine binding protein examined by protein domain coarse-grained molecular dynamics.
Siuda I; Thøgersen L
J Mol Model; 2013 Nov; 19(11):4931-45. PubMed ID: 24048570
[TBL] [Abstract][Full Text] [Related]
15. Flexibility of the flap in the active site of BACE1 as revealed by crystal structures and molecular dynamics simulations.
Xu Y; Li MJ; Greenblatt H; Chen W; Paz A; Dym O; Peleg Y; Chen T; Shen X; He J; Jiang H; Silman I; Sussman JL
Acta Crystallogr D Biol Crystallogr; 2012 Jan; 68(Pt 1):13-25. PubMed ID: 22194329
[TBL] [Abstract][Full Text] [Related]
16. Probing substrate recognition of bacterial lipoprotein signal peptidase using FRET reporters.
Kitamura S; Wolan DW
FEBS Lett; 2018 Jul; 592(13):2289-2296. PubMed ID: 29885279
[TBL] [Abstract][Full Text] [Related]
17. Structure of a lipid A phosphoethanolamine transferase suggests how conformational changes govern substrate binding.
Anandan A; Evans GL; Condic-Jurkic K; O'Mara ML; John CM; Phillips NJ; Jarvis GA; Wills SS; Stubbs KA; Moraes I; Kahler CM; Vrielink A
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2218-2223. PubMed ID: 28193899
[TBL] [Abstract][Full Text] [Related]
18. Maturation of Streptococcus pneumoniae lipoproteins by a type II signal peptidase is required for ABC transporter function and full virulence.
Khandavilli S; Homer KA; Yuste J; Basavanna S; Mitchell T; Brown JS
Mol Microbiol; 2008 Feb; 67(3):541-57. PubMed ID: 18086214
[TBL] [Abstract][Full Text] [Related]
19. Stringency of bacterial prolipoprotein signal peptidase (LspA) in recognition of signal peptides - Structure-function correlation.
Sangith N; Sankaran K
Biochem Biophys Res Commun; 2017 Jun; 488(2):413-417. PubMed ID: 28506828
[TBL] [Abstract][Full Text] [Related]
20. Myxobacterium-produced antibiotic TA (myxovirescin) inhibits type II signal peptidase.
Xiao Y; Gerth K; Müller R; Wall D
Antimicrob Agents Chemother; 2012 Apr; 56(4):2014-21. PubMed ID: 22232277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
